With our long history in healthcare, Fresenius Kabi is well established in the manufacture and supply of products spanning a variety of therapeutic areas. Benefiting from our extensive experience in injectables and complex formulations, we manufacture a comprehensive range of medical devices for the safe administration of our products.
We are now leveraging our experience and company values to offer high-quality biosimilars with a focus on autoimmune and oncology therapy areas.
Fresenius Kabi biosimilars specialize in:
- Treating diseases of the autoimmune system and oncology
- Developing and commercializing high-standard biosimilars, meeting the high standards of EU and US regulators
- Focusing on our biosimilars’ unique ability to improve access for patients, allowing them more affordable treatment
- Developing a strong pipeline of biosimilar molecules to be launched soon
- Bringing patient insights and understanding to life, to go beyond in our level of care
- Encouraging innovation in the biologics field